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CRISPR-Cas9–Mediated Epitope Tagging Provides
Accurate and Versatile Assessment of Myocardin—Brief Report
Qing Lyu, Vidhi Dhagia, Yu Han, Bing Guo, Mary E. Wines-Samuelson,
Christine K. Christie, Qiangzong Yin, Orazio J. Slivano, Paul Herring, Xiaochun Long,
Sachin A. Gupte, Joseph M. Miano
Objective—Unreliable antibodies often hinder the accurate detection of an endogenous protein, and this is particularly true
for the cardiac and smooth muscle cofactor, MYOCD (myocardin). Accordingly, the mouse Myocd locus was targeted
with 2 independent epitope tags for the unambiguous expression, localization, and activity of MYOCD protein.
Approach and Results—3cCRISPR (3-component clustered regularly interspaced short palindromic repeat) was used to
engineer a carboxyl-terminal 3×FLAG or 3×HA epitope tag in mouse embryos. Western blotting with antibodies to
each tag revealed a MYOCD protein product of ≈150 kDa, a size considerably larger than that reported in virtually all
publications. MYOCD protein was most abundant in some adult smooth muscle-containing tissues with surprisingly
low-level expression in the heart. Both alleles of Myocd are active in aorta because a 2-fold increase in protein was seen
in mice homozygous versus heterozygous for FLAG-tagged Myocd. ChIP (chromatin immunoprecipitation)–quantitative
polymerase chain reaction studies provide proof-of-principle data demonstrating the utility of this mouse line in
conducting genome-wide ChIP-seq studies to ascertain the full complement of MYOCD-dependent target genes in vivo.
Although FLAG-tagged MYOCD protein was undetectable in sections of adult mouse tissues, low-passaged vascular
smooth muscle cells exhibited expected nuclear localization.
Conclusions—This report validates new mouse models for analyzing MYOCD protein expression, localization, and binding
activity in vivo and highlights the need for rigorous authentication of antibodies in biomedical research.
Visual Overview—An online visual overview is available for this article.   (Arterioscler Thromb Vasc Biol. 2018;38:21842190. DOI: 10.1161/ATVBAHA.118.311171.)
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Materials and Methods

he trustworthy detection, localization, and interactive association of a protein are essential in understanding cellular
processes under normal and pathological conditions. Yet, biology
is plagued by fallacious antibodies,1 particularly, those directed
against transcription factors.2 Accordingly, antibodies to a variety
of epitope tags have been developed to circumvent the difficulties often encountered with monoclonal or polyclonal antibodies.3 Epitope tagging is commonplace in laboratories using
plasmids to study ectopic protein expression. Far fewer examples
exist with the tagging of endogenous protein-coding gene loci
in mice,4–6 likely because of the labor-intensive approach of traditional gene targeting. However, the CRISPR-Cas9 (clustered
regularly interspaced short palindromic repeat–associated protein
9) genome-editing system7–9 has revolutionized the production of
novel mouse strains, including those carrying epitope tags.10,11
Here, we present the accurate expression, localization, and binding activity of epitope-tagged MYOCD (myocardin), an SRF
(serum response factor) cofactor12 that powerfully drives the program of vascular smooth muscle cell (VSMC) differentiation.13–16

Data available on request from the authors.

Three-Component CRISPR Editing of the
Myocd Locus
For the Myocd3×FLAG mouse, single guide RNA (sgRNA) of
sequence ACAGCAGUGGUAAACACCCG (synthesized in vitro as
described17) was tested for activity in a split reporter assay18 (Figure
IIB in the online-only Data Supplement) and injected (50 ng/µl) with
Cas9 mRNA (100 ng/μL; TriLink Biotechnologies) and a symmetrical, single-strand oligonucleotide containing the 3×FLAG sequence
(100 ng/μL; Ultramer PAGE-purified; Integrated DNA Technologies)
into the pronucleus of C57BL/6J zygotes. The single-strand oligonucleotide was of the same strand as the sgRNA so as to prevent hybridization of the two in the embryo. For the Myocd3×HA mouse, synthetic
sgRNA (same as above) and CAS9 protein (both from Synthego) were
validated for DNA cleavage in an in vitro tube assay as described by
the manufacturer. CAS9 protein and sgRNA were mixed (3 pmol
each) as a ribonucleoprotein complex and then combined with a
249 single-strand Megamer oligonucleotide (100 ng/μL; Integrated
DNA Technologies) before cytoplasmic injection. Viable 2-cell stage
embryos were transferred to pseudopregnant C57BL/6J females.
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Nonstandard Abbreviations and Acronyms
3cCRISPR
Cas9
CRISPR
MYOCD
qPCR
sgRNA
SRF
VSMC

3-component CRISPR
CRISPR-associated protein 9
clustered regularly interspaced short palindromic repeats
myocardin
quantitative polymerase chain reaction
single guide RNA
serum response factor
vascular smooth muscle cell(s)

Local Institutional Animal Care and Use Committees approved
all mouse studies.

Mouse Pup Genotyping, Off-Targeting, and Breeding
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One-week-old founder pups were toe-clipped or ear-punched, and
tissue was digested overnight at 55°C in lysis buffer (50 mmol/L
KCl, 10 mmol/L Tris-HCl [pH 9], 0.1% Triton X-100, and 0.2
mg/mL proteinase K) on an interval mixer. The next morning,
samples were heated at 95°C for 10 minutes to inactivate the proteinase K and spun down at 15 000g for 10 minutes. Each sample
of DNA (1 μL) was mixed with 12 μL nuclease-free water, 10 μL
AccuStart II Supermix (Quantabio), and 1 μL each of forward
and reverse primers (Table I in the online-only Data Supplement)
flanking the double-strand break (Figure II in the online-only
Data Supplement). Polymerase chain reaction (PCR) conditions
were 1 cycle of 95°C for 3 minutes followed by 30 cycles of 95°C
(30 s), 58°C (45 s), and 72°C (1 minute) and a final 7-minute
cycle at 72°C.
Off-targeting was assessed initially with CCTop,19 CasOFFinder,20 and the MIT CRISPR website21 and later with the
CRISPOR tool.22 No predicted off-targets were found within
2 megabases of the on-target double-strand break. We selected
the top 9 distal off-target sites based on an aggregate analysis of
each prediction program. PCR primers flanking each predicted
off-target site were synthesized (Integrated DNA Technologies)
and used to amplify genomic DNA from founder mice as above
only the number of PCR cycles was limited to 28. Each primer
pair contained linker sequences positioned at the 5’ end of the
template-specific primer sequence necessary for next-generation
sequencing; the forward primers contained the linker sequence,
ACACTGACGACATGGTTCTACA, and the reverse primers contained the linker sequence, TACGGTAGCAGAGACTTGGTCT.
After the initial 28-cycle PCR reaction, the samples were verified on an agarose gel, and approximately equal amounts were
subjected to a second PCR reaction (8 cycles only) using primers containing Illumina adaptor sequence, 10 bp sample-specific
barcodes, and the original linker sequences. Amplified sequences
were then submitted to the Genomics Core for next-generation
sequencing on an Illumina HiSeq 2500 platform. This setup
allowed for all 9 amplicons to be sequenced in 1 lane of the
sequencer. Raw sequence reads were analyzed for indels with
CRISPResso.23
Positive founder mice derived from CRISPR-Cas9 genome
editing are mosaic.11,24 We, therefore, backcrossed each positive
founder to C57BL/6J mice for Sanger sequencing to confirm germline transmission of each epitope tag. Sanger sequencing of F1 mice
confirmed germline transmission of the correct allele, as well as
sequence fidelity in and around the edited region. Myocd3×FLAG was
successfully bred through the germline (in 2 founders), and data
were similar in both lines. We confirmed 1 mosaic founder carrying the Myocd3×HA tag, but the line was lost because of dystocia of
the pregnant founder. We nevertheless isolated tissues for Western
(Figure 1B) and limited immunofluorescence microscopy of adult
tissues (data not shown). Each of the CRISPR-edited mouse lines
is listed in the Major Resources Table in the in the online-only
Data Supplement.

RNA Isolation, Reverse Transcription,
and Real-Time qPCR
Total RNAs were isolated using RNeasy Mini Kit (Qiagen, no.
74104) according to the manufacturer’s instructions. Reverse transcription was performed using Bio-Rad iScript cDNA synthesis kit
(Bio-Rad, no. 1708891) after RNA quantification and DNase I treatment. Real-time quantitative PCR (qPCR) was performed using iTaq
Universal SYBR Green Supermix (Bio-Rad, no. 1725121) with customized primers (Table I in the online-only Data Supplement).

Western Blot
Tissues (from male and female mice, aged 6–10 weeks) were isolated and homogenized in 200 μL of cell lysis buffer (Cell Signaling,
no. 9803). After brief centrifugation, supernatants were transferred
to fresh 1.5 mL microfuge tubes for protein quantification with DC
protein assay kit (Bio-Rad, no. 5000111). Samples were boiled in
LDS sampling buffer (Invitrogen, no. NP0007) and subjected to
electrophoresis in SDS-PAGE gel. Proteins were transferred to
a polyvinylidene difluoride membrane for 2 hours in cold room at
80 V using a Trans-blot machine (Bio-Rad). Membranes were then
blocked with 5% nonfat milk in TBS-T (Tris-buffered saline containing 0.1% Tween 20) for 1 hour and incubated with primary antibody
for 1 hour at room temperature. After washing, secondary antibodies
were incubated for 1 hour at room temperature followed by immersion in chemiluminescence substrate (Thermo Fisher, no. 34080) and
exposed to X-ray film. A list of antibodies used is provided in the
Major Resource Table in the online-only Data Supplement.

Chromatin Immunoprecipitation
At least 5 mouse aortae were isolated and fixed in 10 mL of 4% paraformaldehyde at room temperature for 10 minutes. One mL of 1.25
mol/L glycine was added to stop crosslinking. Aortae were washed
twice with 1×PBS and 1 mL of ChIP (chromatin immunoprecipitation) lysis buffer (50 mmol/L Tris-HCl [pH 8.0], 150 mmol/L NaCl,
5 mmol/L EDTA, 0.1% deoxycholate, 1% Triton X-100, and protease inhibitor cocktail) was added. Tissues were then pulse-sonicated
(intervals of 10 s pulse for 2 minutes) and centrifuged at 12 000g for
10 minutes at 4°C. Supernatants were collected and transferred to
fresh 1.5 mL microfuge tubes. Mouse anti-FLAG antibody (SigmaAldrich, no. F3165) and mouse IgG were added to lysate (≈500 μL
each) respectively and incubated for 2 hours at 4°C. One-hundred
microliters of Dynabeads protein G (Thermo Fisher, no. 10003D)
were washed twice with 1×PBS and resuspended in the original volume of ChIP lysis buffer for each ChIP reaction. Magnetic beads were
mixed with antibody-lysate and incubated for 2 hours at 4°C. After 5
washes with ChIP lysis buffer, samples were treated with proteinase
K (10 mg/mL) at 55°C on a thermomixer for 1 hour. DNA was then
recovered and purified by boiling with Chelex-100 resin (Bio-Rad,
no. 1422822) for downstream assays, (eg, real-time qPCR).

Isolation and Culture of Mouse Aortic Smooth
Muscle Cells
We followed a previously published protocol for isolating mouse aortic SMC.25 In brief, for each independent experiment, 3 mouse aortae
were isolated and placed into ice-cold Hank’s balanced salt solution
in a 15 mL conical tube. Aortae were digested with 3 mL of buffer
A (10 mg collagenase II, 10 mg soybean trypsin inhibitor in 10 mL
Hank’s balanced salt solution) at 37°C for 20 minutes. Aortae were
then transferred into clean culture dishes loaded with 10 mL buffer B
(DMEM/F12 medium with 20% FBS and 1% Pen-Strep, prewarmed
to 37°C). The adventitial layer was peeled off using fine forceps,
and aortae were transferred into another clean culture dish with 10
mL buffer B. Each aorta was then cut longitudinally, and the intimal
layer was scraped with angled blunt forceps to remove endothelial
cells. Aortae were cut with fine scissors into 1 to 2 mm pieces and
transferred to 1 well of a 6-well culture plate with 3 mL buffer C (3
mL buffer B+67 μL elastase [Worthington, no. LS002279] at 24.8
mg/mL). Tissues were incubated for 15 minutes at 37°C followed by
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Figure 1. In vivo MYOCD (myocardin) protein expression and binding activity. A, Western blot of MYOCD3×FLAG in wild-type (wt; +/+) vs heterozygous
and homozygous FLAG (FL)-tagged MYOCD in indicated male mouse tissues. HEK-293 cells untransfected (−) or transfected (+) with 3×FLAG-tagged
v1 isoform of MYOCD served as a control. B, Parallel Western blots of MYOCD3×FLAG or MYOCD3×HA tagged tissues. C, Tissue profile of MYOCD3×FLAG
expression in indicated female tissues. Similar results were seen in several independent experiments during the course of 2 y. D, In vivo ChIP (chromatin
immunoprecipitation)–quantitative polymerase chain reaction (PCR) in homozygous Myocd3×FLAG aortae for the indicated target genes using FLAG or IgG control antibodies (Ab). Data are expressed as fold enrichment of FLAG sequence over IgG control. All results were confirmed in at least 1 independent experiment. Data passed test for normality and paired t test showed significantly increased enrichment of PCR products with the anti-FLAG antibody, P<0.01. Sk
mus indicates skeletal muscle; Stom, stomach; and TUBB, beta tubulin.
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repeated pipetting with cut 1 mL tips to loosen cells. Cells were incubated another 15 minutes at 37°C and dissociated cells were repeat
pipetted with uncut 1 mL tip 5 to 6×. The digestion mixture was transferred to a clean 15 mL canonical tube and 3 mL buffer A was added
to stop digestion. Samples were centrifuged at 800g for 5 minutes
at 4°C to pellet cells. Cells were resuspended in 5 mL buffer A and
plated in a well of 6-well plate. Isolated mouse smooth muscle cells
were studied on reaching 50% to 70% confluency.

Confocal Microscopy
Mouse aortic smooth muscle cells were cultured on 22×22 mm coverslips in 6-well plates. Cells were fixed with 4% paraformaldehyde
for 10 minutes at room temperature. Coverslips were rinsed in 1×PBS
twice and cells permeabilized with 1×PBS containing 0.1% Triton
X-100 on an ice bath. Cells were blocked with 3% BSA for 20 minutes
at room temperature, and anti-FLAG primary antibody (Sigma-Aldrich,
no. F1804; 1:100 dilution) was applied at room temperature for 40 minutes. Coverslips were rinsed twice with 1×PBS and cells incubated with
fluorescence-conjugated secondary antibodies (1:200) for 40 minutes at
room temperature. Cells were then mounted with ProLong Gold antifade reagent with DAPI (4’,6-diamidino-2-phenylindole, dihydrochloride; Thermo Fisher, no. P36935) and examined with an Olympus
IX81 confocal microscope using uniform settings for all conditions.

Flow Cytometry
Aortae derived from the mTmG/Myh11CreERT2 cross were digested
as mentioned above, and freshly dissociated mouse aortic smooth
muscle cells were resuspended in PBS and submitted to the University
of Rochester Medical Center Flow Cytometry Core. Cells were sorted
according to the Tomato (610 nm) or GFP (green fluorescent protein;
510 nm) signal and quantitated as a percentage of total cells stained
for GFP or Tomato.

Transfection Assays
Rat aortic smooth muscle cells (A7r5, ATCC CRL-1444) were transfected with either Myocd short intervening RNA (si-Myocd, catalog

no. SASI_Rn01_00118674, Sigma-Aldrich) or MISSION siRNA
Universal Negative Control (si-Scramble, catalog no. SIC001; SigmaAldrich). Cells were mixed with DharmaFECT1 transfection reagent
(Lipofectamine 2000, catalog no. T2001-02; Dharmacon) in a 1:1
ratio followed by incubation at room temperature for 20 minutes.
Cell mixtures were then added to the wells of cell plates followed by
incubation for 48 hours at 37°C. After incubation, cells were washed
twice with ice-cold PBS, scraped, and collected in either NP-40
lysis buffer (50 mmol/L Tris-HCl [pH 7.4], 150 mmol/L NaCl, 0.5%
Nonidet P-40) containing EDTA-free complete protease and phosphatase inhibitor (Sigma-Aldrich/Roche) for protein estimation or
Qiazol buffer for mRNA measurement. For protein measurement, 20
μg samples were run on SDS-PAGE gels, transferred to nitrocellulose
membrane, blocked with 4% nonfat milk, and subsequently incubated
with TUBA1A (anti-α-tubulin, catalog no. sc5286; Santa Cruz), or
MYOCD (catalog no. ab22073; Abcam), followed by incubation
with secondary antibodies and detection using SuperSignal West
Pico Chemiluminescent Substrate (catalog no. 34080; Thermo Fisher
Scientific) on autoradiography film. For Myocd mRNA levels total
RNA was extracted from aorta and bladder using a Qiagen miRNeasy
kit (catalog no. 217004). Input RNA quality and concentration were
measured using a Synergy HT Take3 Microplate Reader (BioTek,
Winooski, VT), and cDNA was prepared using SuperScript IV VILO
Master Mix (catalog no. 11756500, Invitrogen). qPCR was performed
in triplicate using TaqMan Fast Advanced Master Mix (catalog no.
44-445-57) in an Mx3000p Real-Time PCR System (Stratagene, Santa
Clara, CA). The primers for Myocd (Assay ID no. Rn01786178) were
purchased from Thermo Fisher Scientific/TaqMan. Results of mRNA
expression were normalized to internal control Gapdh, and relative
mRNA expression was determined using the ΔΔCt method.

Nano-Liquid Chromatography-Tandem Mass
Spectrometry
Rat aorta, urinary bladder, and A7r5 cells were homogenized and
lysed in lysis buffer (50 mmol/L Tris-HCl [pH 7.4], 150 mmol/L
NaCl, 0.5% Nonidet P-40) containing EDTA-free complete protease and phosphatase inhibitor (Sigma-Aldrich/Roche). Protein levels were measured using Bradford assays (Bio-Rad), after which 30
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μg samples were run on SDS-PAGE gels followed by fixing the gel
(50% methanol and 10% acetic acid) for 40 minutes at room temperature and washing for 1 hour. Bands corresponding to 100 kDa
were cut and subjected to mass spectrometry analysis. The proteins
were eluted and analyzed using liquid chromatography-tandem mass
spectrometry (Applied Biomics, Hayward, CA). Nano-liquid chromatography fractionation and matrix-assisted laser desorption ionization-time of flight/time of flight were followed by a standard search
of the National Center for Biotechnology Information and SwissProt
databases using MASCOT. The ≈150 kDa FLAG-tagged MYOCD
band from mouse bladder was similarly processed and analyzed.

Statistical Analyses
Primary data were assessed for normality with a Shapiro-Wilk test
for equal variance (in case of 1- or 2-way ANOVA), and all datasets displayed normal distributions and variances. Accordingly, we
used parametric paired t test for comparisons between experimental
and control conditions or 1- and 2-way ANOVA for multiple group
comparisons. All data analysis was performed in GraphPad Prism 7.
Results are expressed as mean±SD. A value of P<0.05 was considered statistically significant. For mendelian inheritance of different
alleles we used a χ2 test.

Results
In Vivo MYOCD Protein Expression and
Binding Activity
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There are at least 4 MYOCD isoforms with predicted molecular
weights of 106 kDa (v1, 983 amino acids), 101 kDa (v2, 935
amino acids), 97 kDa (v3, 904 amino acids), and 92 kDa (v4, 856
amino acid).26,27 Most commercial antibodies report endogenous
MYOCD protein of ≈100 kDa, consistent with the predicted
molecular weights of each isoform. However, on knockdown of
Myocd mRNA, there was no corresponding change in a widely
assumed MYOCD protein band in A7r5 SMC, mouse and rat
aorta and bladder, mouse aortic SMC, and human coronary
artery SMC (Figure IB in the online-only Data Supplement and
data not shown). Similar results were found using a different
siRNA to Myocd in mouse aortic smooth muscle cell (Figure
IC in the online-only Data Supplement). Mass spectrometry of
the excised 100 kDa bands from rat aorta and bladder, as well as
the A7r5 SMC line, revealed no evidence of MYOCD peptides
(Table II in the online-only Data Supplement). Thus, although
many commercial antibodies are able to reveal ectopic MYOCD
expression (not shown), there is a question as to the accuracy of
detecting the endogenous MYOCD protein.
Accordingly, 3-component CRISPR11 was used to target
the last coding exon of Myocd with either 3×FLAG or 3×HA
epitope tags (Figure IIA in the online-only Data Supplement).
Correct targeting was validated by Sanger sequencing in
3×FLAG (4/35), and 3×HA (1/6) founders with no predicted
off-targeting in linkage disequilibrium with the on-target site;
sequence analysis of the top 9 predicted distal off-target sites
showed no mutations, consistent with the high specificity
of the sgRNA (data not shown). The Myocd3×FLAG allele was
bred through the germline, and sibling-matings revealed an
expected mendelian ratio (Figure IID in the online-only Data
Supplement). Western blotting supported biallelic expression of
the Myocd gene (Figure 1A). The estimated molecular weight
of FLAG-tagged MYOCD was ≈150 kDa, a size considerably larger than that reported in the literature; Myocd3×HA mice
showed a similar sized band (Figure 1B). An independently

generated Myocdmyc-HA mouse also revealed MYOCD to have
a molecular mass of ≈150 kDa (Figure IIIA in the online-only
Data Supplement). Adult tissue profiling showed the highest
expression of MYOCD in bladder and uterus with moderate
levels in the aorta; surprisingly lower levels of MYOCD protein were consistently seen in the adult heart (Figure 1C and
Figure IIIB in the online-only Data Supplement). Importantly,
mass spectrometry analysis of the 150 kDa band revealed small
quantities of MYOCD protein (Table III in the online-only Data
Supplement). ChIP-qPCR of Myocd3×FLAG aortic tissue showed
significant enrichment of SRF-binding CArG sequences around
several known targets of the SRF-MYOCD transcriptional
switch (Figure 1D). Despite repeated efforts under numerous
experimental conditions, no consistent MYOCD signal was
obtained on tissue sections with an array of antibodies to FLAG
(data not shown). These in vivo findings reveal a higher molecular weight of MYOCD than previously reported and define,
for the first time, reliable detection of endogenous MYOCD
protein expression and binding activity in adult mouse tissues.

In Vitro MYOCD Protein Expression
The mTmG reporter mouse28 was crossed with the
Myh11CreERT2 mouse29 to indelibly mark VSMC of the aortic
wall with GFP. Most aortic cells from passage numbers 1 to 4
are GFP+; however, beginning at passage number 5 a notable
decrease in GFP+ VSMC was seen (Figure IV in the onlineonly Data Supplement). Thus, in vitro studies were restricted
to cultures of mouse VSMC at passage 1 to 3. Homozygous
Myocd3×FLAG VSMC exhibited similar mRNA levels of SRF/
MYOCD target genes as in wild-type VSMC, suggesting the
FLAG epitope tag did not adversely affect MYOCD activity
(Figure VA in the online-only Data Supplement). Western blotting of passage 2 VSMC showed MYOCD protein comparable
in size to that seen in tissues, indicating the molecular weight
of MYOCD did not change appreciably on culture (Figure VB
in the online-only Data Supplement). Immunofluorescence
microscopy disclosed nuclear-localized MYOCD in cultured
VSMC (Figure 2A). Knockdown of Myocd mRNA (Figure 2B)
resulted in reduced VSMC FLAG-tagged MYOCD protein
expression (Figure 2C and Figure VB–VC in the online-only
Data Supplement); we estimate a reduction of at least 10-fold
over si-control treated VSMC (Figure 2D). Collectively, these
results authenticate a new mouse model for accurate detection
of MYOCD protein in both adult tissues and cultured VSMC.

Discussion
We introduce new myocd mouse models wherein epitope tags
(3×FLAG and 3×HA) were used to independently target the last
coding exon of the Myocd locus. The motivation for generating
these mice stems from our long-standing difficulty in assessing
endogenous levels of MYOCD protein expression in vivo or in
vitro in mouse, human, and rat.30 The initial characterization of
the epitope-tagged mice reported here reveals several notable
findings. First, the 2-fold increase in MYOCD protein expression of homozygous versus heterozygous Myocd3×FLAG mice
indicates biallelic gene transcription. Second, multiple epitope tags demonstrate the molecular weight of the endogenous
MYOCD protein to be much higher (≈150 kDa) than formerly
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Figure 2. In vitro MYOCD (myocardin) protein expression. A, Immunofluorescence microscopy of MYOCD3×FLAG in low-passaged mouse aortic smooth muscle
cells (MASMC). Note abundant nuclear staining in Myocd3×FLAG MASMC vs wild-type controls. B, Quantitative real-time polymerase chain reaction following
siRNA knockdown of Myocd mRNA in cultured MASMC. C, Immunofluorescence microscopy of MYOCD3×FLAG in MYH11 positive MASMC treated with si
scrambled control (siCtrl, top) or siMyocd (bottom). Scale bar here and in A is 10 μm. D, Quantitative analysis (by 2 independent, blinded investigators) of
number of MYOCD-FLAG positive cells costaining for MYH11. See also Figure VC in the online-only Data Supplement. DAPI indicates 4’,6-diamidino-2-phenylindole, dihydrochloride.

reported. Indeed, with rare exception,31 the molecular weight
of MYOCD protein, when reported, has been between 95 to
105 kDa. We show in data from 2 independent laboratories,
using distinct reagents and cell types, that a putative MYOCD
protein of ≈100 kDa does not change with siRNA knockdown
of Myocd mRNA. We, therefore, caution investigators using
commercial antibodies to MYOCD and urge rigorous analysis to authenticate the specificity of bands so as to avoid further confusion in the field. The higher molecular weight of
MYOCD over its predicted size of ≈100 kDa likely reflects
several post-translational modifications shown previously
to occur in MYOCD, at least in cultured model systems.30,32
Precision CRISPR editing of key amino acids undergoing
post-translational modification in the Myocd3×FLAG mouse may
clarify the higher-than-expected molecular weight of MYOCD
and reveal more nuanced phenotypes than those reported in
conditional Myocd knockouts of the heart and vessel wall.33,34
Lower molecular weight bands were seen with FLAG antibodies, particularly in aorta, bladder, and uterus (Figure 1 and
Figures III and V in the online-only Data Supplement). The identity of these bands is unknown at this time, but they could represent different MYOCD isoforms, differential post-translational
modifications of a specific MYOCD isoform, or proteolytic
cleavage products of MYOCD. The targeting of the C terminus

of MYOCD with epitope tags, as reported here, should allow for
the detection and functional assessment, via precision CRISPR
editing, of all previously described MYOCD isoforms.26,27
Another noteworthy result was the low-level MYOCD protein in adult heart. This finding was seen in every experiment
conducted and cannot be attributed to lower mRNA levels
because we originally reported Myocd mRNA to be equivalent
in heart and aorta,13 a finding we have repeated here (Figure
VI in the online-only Data Supplement). The lower levels
of MYOCD protein in adult heart, as compared to bladder
and aorta, could reflect a known mechanism of microRNAmediated repression during cardiac development. Such repression was shown to promote cardiomyocyte maturation while
repressing the VSMC gene program.35,36 Interestingly, Myocd
mRNA is elevated in heart failure,37 a condition characterized
by the re-emergence of the fetal heart gene program, which
includes an array of VSMC genes. Thus, it seems that levels
of MYOCD protein are under exquisite control in the normal
adult heart for optimal cardiac function.
The use of a FLAG antibody in ChIP-qPCR studies provides proof-of-principle data supporting ChIP-seq studies in the
vessel wall under normal or stress-induced conditions. In this
context, a growing number of SRF-independent target genes
of MYOCD have been reported.30 The ability to generate mice
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in which each Myocd allele carries either a 3×FLAG or 3×HA
tag offers a rigorous approach to define novel DNA binding
sequences and the corresponding DNA-binding transcription
factors associated with MYOCD. The mice reported here will
also be useful for the discovery of new MYOCD binding proteins or RNAs, especially the class of long noncoding RNA.
These and other studies will further illuminate MYOCD biology, thus providing a more integrative understanding of how this
cofactor functions under normal and pathological conditions.
In contrast to adult tissues, nuclear-localized MYOCD was
observed consistently in cultured VSMC as demonstrated in
siRNA knockdown studies. Previous mouse studies showed
FLAG-tagged protein expression in tissue sections38 suggesting
there may be some steric hindrance in detecting the MYOCD
protein in vivo. It is possible the epitope is masked through
interactions of MYOCD with other molecules in the cell.30,32
However, we have observed consistent staining in adult mouse
tissues carrying an inducible HA-tagged Myocd transgene
(unpublished), and preliminary staining of aorta carrying the
Myocd3×HA tag suggests that it could be a more discriminating epitope tag than 3×FLAG for immunostaining, though this
will require further analysis. Importantly, genetically marked
VSMC progressively decrease from culture indicating the need
for careful experimental design and circumspect conclusions
drawn from in vitro primary VSMC experiments.
The CRISPR revolution has expedited the generation
of new mouse models.11 We anticipate similarly tagged
mice, as those reported here, will be developed for rigorous protein analyses and accelerated discoveries in vascular
biology.
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• Nondiscriminating antibodies have hampered the reliable detection of MYOCD (myocardin) protein.
• CRISPR-Cas9 (clustered regularly interspaced short palindromic repeat–associated protein 9) genome editing was used to knock-in epitope
tags at the C-terminal end of the myocd locus.
• The molecular mass of MYOCD protein is ≈150 kDa, a size much larger than that reported in the vast literature.
• Epitope tagging of MYOCD allows for facile detection of nuclear MYOCD in cultured cells, as well as associated DNA binding as revealed with
ChIP (chromatin immunoprecipitation)–quantitative polymerase chain reaction.
• Epitope tagging of genes with CRISPR affords an unambiguous assessment of protein expression, localization, and associated interactions in
the cell.

